BioSpace News Archive

Bristol-Myers Squibb Company will take part in a fireside chat at the Wolfe Research Healthcare Conference on Wednesday, November 6, 2019, in New York.

ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, announced that it has initiated the Phase 3 LAVENDER placebo-controlled study to evaluate the efficacy and safety of trofinetide for girls and young women with Rett syndrome.

Kaiser Permanente research identifies national trend linked to aging of baby boomers and upturn in heart disease mortality

Satralizumab represents a potential new approach to treating neuromyelitis optica spectrum disorder (NMOSD), a rare, debilitating disease often misdiagnosed as multiple sclerosis (MS)

Victor L. Nannini, DDS, FACS, was introduced as the 102nd president of the American Association of Oral and Maxillofacial Surgeons during its Annual Meeting in September in Boston, Mass..

Medivir AB announces that a poster entitled “MIV-818 stimulates an anti-tumor immune response in vitro and enhances the effects of pembrolizumab” was presented at the AACR-NCI-EORTC conference in Boston.

Scientific American has published Taiwan Healthcare & Life Sciences Review, a country-focused report presenting a comprehensive insight on biotech ecosystem of Taiwan.

Analysis Identifies the 10 Major U.S. Cities Most Likely to Suffer a Shortage of Oncologists

ESSA Pharma Inc. announced that, pursuant to its stock option plan, it has granted incentive stock options to non – executive members of the Corporation’s board of directors to purchase up to an aggregate of 225,000 common shares in the capital of the Corporation.

BWX Technologies, Inc. announced that it plans to produce the medical radioisotope Germanium-68 with a focus on addressing a growing global demand for the product..